Market Cap (In INR)
10.51 Billion
Revenue (In INR)
6.14 Billion
Net Income (In INR)
509.56 Million
Avg. Volume
72.76 Thousand
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 198.05-369.2
- PE
- -
- EPS
- -
- Beta Value
- 0.578
- ISIN
- INE082A01010
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Mr. Surendra Shrikrishna Somani B.Com.
- Employee Count
- -
- Website
- https://www.kopran.com
- Ipo Date
- 2000-01-03
- Details
- Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as topical preparations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. In addition, the company provides drugs for erectile dysfunction, antiallergics, respiratory, oncology, central nervous system, antiprotozoal, anthelmintics, antipeptic ulcer and gut, and others. Kopran Limited was incorporated in 1958 and is headquartered in Mumbai, India.
More Stocks
-
MYTE
-
SWYDF
-
002555
-
ORGN
-
ZNG
-
PRMRFParamount Resources Ltd.
PRMRF
-
300304
-
002558